These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 7826595)

  • 1. Ursodeoxycholic acid in the treatment of primary sclerosing cholangitis.
    Stiehl A
    Ann Med; 1994 Oct; 26(5):345-9. PubMed ID: 7826595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of cholestatic liver disease].
    Pleşa A
    Rev Med Chir Soc Med Nat Iasi; 2003; 107(4):733-6. PubMed ID: 14756010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Importance of liver puncture biopsy and endoscopic retrograde cholangiography in patients with chronic anicteric unexplained cholestasis. A retrospective study in 79 patients].
    Sapey T; Turlin B; Canva-Delcambre V; Mendler MH; Deugnier Y; Brissot P; Guyader D
    Gastroenterol Clin Biol; 1999 Feb; 23(2):178-85. PubMed ID: 10353011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Possible treatment modalities of primary sclerosing cholangitis].
    Lengyel G; Tulassay Z
    Orv Hetil; 2005 Dec; 146(49):2479-83. PubMed ID: 16398312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Primary sclerosing cholangitis: present views of its pathogenesis, diagnosis and treatment].
    Aleksandrova EA; Avdeev VG; Burnevich EZ; Arion EA
    Ter Arkh; 2012; 84(8):86-90. PubMed ID: 22994098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenetic aspects of primary sclerosing cholangitis: implications for therapeutic strategies.
    van Milligen de Wit AW; van Deventer SJ; Tytgat GN
    Am J Gastroenterol; 1995 Jun; 90(6):893-900. PubMed ID: 7771416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis.
    Fickert P; Hirschfield GM; Denk G; Marschall HU; Altorjay I; Färkkilä M; Schramm C; Spengler U; Chapman R; Bergquist A; Schrumpf E; Nevens F; Trivedi P; Reiter FP; Tornai I; Halilbasic E; Greinwald R; Pröls M; Manns MP; Trauner M;
    J Hepatol; 2017 Sep; 67(3):549-558. PubMed ID: 28529147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ursodeoxycholic acid therapy in treatment of primary sclerosing cholangitis.
    Stiehl A
    Scand J Gastroenterol Suppl; 1994; 204():59-61. PubMed ID: 7824879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Primary sclerosing cholangitis--diagnosis and therapy].
    Virović L; Supanc V; Duvnjak M
    Acta Med Croatica; 2003; 57(3):207-19. PubMed ID: 14582467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The management of primary sclerosing cholangitis.
    Mitchell SA; Chapman RW
    Clin Liver Dis; 1998 May; 2(2):353-72, x. PubMed ID: 15560037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and classification of primary sclerosing cholangitis.
    Yimam KK; Bowlus CL
    Autoimmun Rev; 2014; 13(4-5):445-50. PubMed ID: 24424180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis.
    Mitchell SA; Bansi DS; Hunt N; Von Bergmann K; Fleming KA; Chapman RW
    Gastroenterology; 2001 Oct; 121(4):900-7. PubMed ID: 11606503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cholestatic liver diseases].
    Thimme R; Opitz OG; Blum HE; Kreisel W
    Ther Umsch; 2004 Aug; 61(8):521-7. PubMed ID: 15457969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ursodeoxycholic acid on liver and bile duct disease in primary sclerosing cholangitis. A 3-year pilot study with a placebo-controlled study period.
    Stiehl A; Walker S; Stiehl L; Rudolph G; Hofmann WJ; Theilmann L
    J Hepatol; 1994 Jan; 20(1):57-64. PubMed ID: 8201224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary sclerosing cholangitis.
    Rodriguez HJ; Bass NM
    Semin Gastrointest Dis; 2003 Oct; 14(4):189-98. PubMed ID: 14719769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ascending pathophysiology of cholestatic liver disease.
    Jansen PL; Ghallab A; Vartak N; Reif R; Schaap FG; Hampe J; Hengstler JG
    Hepatology; 2017 Feb; 65(2):722-738. PubMed ID: 27981592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic cholestatic liver diseases - Primary biliary cholangitis and Primary sclerosing cholangitis.
    Fejfar T; Vaňásek T; Hůlek P
    Vnitr Lek; 2020; 66(5):287-300. PubMed ID: 32942866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary sclerosing cholangitis: updates in diagnosis and therapy.
    Portincasa P; Vacca M; Moschetta A; Petruzzelli M; Palasciano G; van Erpecum KJ; van Berge-Henegouwen GP
    World J Gastroenterol; 2005 Jan; 11(1):7-16. PubMed ID: 15609388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ursodeoxycholic acid therapy for primary sclerosing cholangitis: results of a 2-year randomized controlled trial to evaluate single versus multiple daily doses.
    van Hoogstraten HJ; Wolfhagen FH; van de Meeberg PC; Kuiper H; Nix GA; Becx MC; Hoek AC; van Houte DP; Rijk MC; Salemans JM; Scherpenisse J; Schrijver M; Smit AM; Spoelstra P; Stadhouders PH; Tan TG; Hop WC; ten Kate FJ; vanBerge-Henegouwen GP; Schalm SW; van Buuren HR
    J Hepatol; 1998 Sep; 29(3):417-23. PubMed ID: 9764988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current treatments of primary sclerosing cholangitis.
    Vacca M; Krawczyk M; Petruzzelli M; Sasso RC; van Erpecum KJ; Palasciano G; van Berge-Henegouwen GP; Moschetta A; Portincasa P
    Curr Med Chem; 2007; 14(19):2081-94. PubMed ID: 17691949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.